“PATHETIC “ is all I can think. This is a joke for all LTH .! Mayne is priced may about its true value. 5 years is a joke for exclusivity. Mayne will spend a fortune marketing and establishing E4 as a great product. it will take 5 years. Nobody but very few people particularly women change their medications. I am absolutely disgusted with management who have known this for ages and are now praising the good news. Of course it’s not price sensitive. 63c back in 2019 on news we were even getting a new product. When deal was done Mayne were 51c and to achieve $200m was a cost with shareholding and cash of A$529m . I honestly believe there is something not quite right to benefit Mayne shareholders. Also it has not been disclosed of Mithra margins to supply product.( fair enough) considering . I just wonder if there is not more to this deal. Very concerned I must say. So very disappointed. !!!!!!’
MYX Price at posting:
37.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)